Soft Tissue Biologics Product Pipeline Report 2023: Reveals Key Development Stages, Industry Trends, Regions, and Companies [Yahoo! Finance]
Anika Therapeutics Inc. (ANIK)
Last anika therapeutics inc. earnings: 2/20 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.anikatherapeutics.com/investor-relations
Company Research
Source: Yahoo! Finance
Countries, Regulatory Path and Key Companies, 2023 Update" report has been added to ResearchAndMarkets.com's offering. This report is pivotal for stakeholders, providing a competitive edge with data on stages of development, regulatory paths, and key companies shaping the future of soft tissue repair and replacement. Soft Tissue Biologics, integral to advancements in surgical interventions, are experiencing a significant transformation with new products in the pipeline challenging traditional repair methods. The newly updated report delves into products at various stages, from nascent development to those on the cusp of commercial release, while highlighting the dynamic landscape of ongoing clinical trials. Report Scope and Insights Detailed coverage of new and existing Soft Tissue Biologics, outlining developmental progress. A review of developmental activities, inclusive of partnerships, licensing, and collaborations. Profiles of major industry players and an assessment
Show less
Read more
Impact Snapshot
Event Time:
ANIK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIK alerts
High impacting Anika Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
ANIK
News
- Anika Therapeutics (NASDAQ:ANIK) shareholders have endured a 37% loss from investing in the stock three years ago [Yahoo! Finance]Yahoo! Finance
- Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024GlobeNewswire
- Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Anika to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceGlobeNewswire
- Anika Therapeutics, Inc. (NASDAQ: ANIK) had its price target raised by analysts at Barrington Research from $29.00 to $37.00. They now have an "outperform" rating on the stock.MarketBeat
ANIK
Earnings
- 3/13/24 - Beat
ANIK
Sec Filings
- 4/26/24 - Form 10-K/A
- 4/5/24 - Form SC
- 3/19/24 - Form 4
- ANIK's page on the SEC website